COPD and the inhaled corticosteroid debate

Sam Lim, Melissa Baraket



The use of inhaled corticosteroids to manage chronic obstructive pulmonary disease (COPD) is controversial. While there is no evidence that they slow the progression of this condition, recent studies suggest that high dose inhaled corticosteroids may decrease exacerbations of COPD and improve quality of life.

Article Extract

Chronic obstructive pulmonary disease (COPD) ranks third behind ischaemic heart disease and stroke as a major cause of disability and early death in Australia (see the box on this page). Yet, COPD has received much less public and research attention than other respiratory diseases, such as asthma.